bioRN News
In 2025, the bioRN cluster experienced a strong and dynamic expansion as many new members joined its growing network. This influx of new companies and institutions further strengthened the cluster’s expertise, diversity, and innovative power. The cluster is now pleased to introduce these new members and highlight the diverse capabilities they bring, further reinforcing its […]
read more
life – the biomedical convention – 30 Jahre bioRN Life Science Cluster: Impulsgeber für die nächste Generation biomedizinischer Innovation
Heidelberg, 15. Januar 2026 – Am 4. Februar 2026 lädt der bioRN Life Science Cluster zur life – the biomedical convention in das Heidelberg Congress Center ein. Die internationale Fachkonferenz bringt Wissenschaft, Industrie, Startups und Innovationsakteure zusammen und zeigt, warum der bioRN Life Science Cluster zu den leistungsfähigsten Life-Science-Ökosystemen Europas zählt. Im Zentrum der eintägigen […]
read more
BioRN strenghthens its Leadership and Governance to reflect a growing life science ecosystem
Heidelberg, 18 December: At its most recent general meeting, bioRN Network e.V. decided on important strategic course corrections for the coming years and elected a strengthened executive board and an expanded strategic advisory board. The changes reflect the continuous growth of the bioRN life science cluster and its efforts to represent the interests of its […]
read more
Workflow Optimisation in the Laboratory: Premiere of the smartLabs Summit in Heidelberg
On September 24, 2025, the smartLabs Summit will open its doors for the first time in Heidelberg – an event dedicated to practical innovation, digitalization, and automation in laboratories. The Summit will take place at BioLabs Heidelberg (Nicola-Tesla Straße 1–3, 69124 Heidelberg) and offers a full program from 1:00 to 7:30 p.m. Initiated by the […]
read more
New Member: Welcome in our cluster to Quantum-Si Incorporated
Quantum-Si is transforming proteomics with a benchtop platform that brings single-molecule protein analysis to every lab, everywhere. The Company’s platform enables real-time kinetic-based detection and allows researchers to move beyond traditional, multistep workflows and directly access dynamic, functional protein insights with unparalleled resolution. By making protein analysis simpler, faster, and more informative, Quantum-Si is accelerating […]
read more
New Member: Welcome in our cluster to aimed analytics GmbH
aimed analytics is a cutting-edge SaaS company providing AI-driven biomedical data analysis. Its platform enables fully automated, scalable, and reproducible analysis of complex omics data—without programming skills. Researchers simply upload data and ask questions in natural language. With rapid, cost-efficient workflows, aimed analytics helps biotech, pharma, and academia accelerate discovery and reduce dependency on scarce […]
read more
New Member: Welcome in our cluster to Data Powered Therapeutics GmbH
dPTx is building a next-generation platform that transforms protein R&D through automation and structured data. By integrating robotic wet-lab workflows with a propriety smart ELN, they generate ML-ready datasets by design—enabling reproducibility, faster iteration, and scalable discovery. Unlike traditional CROs, they offer more than just services: dPTx provides a datapowered engine for protein production and […]
read more
New Member: Welcome in our cluster to BASF SE
BASF creates chemistry for a sustainable future, combining economic success with environmental protection and social responsibility. With about 112,000 employees worldwide, BASF supports customers across nearly all sectors. In pharmaceuticals, BASF delivers high-quality excipients and active ingredients, supporting effective, reliable formulations. With deep expertise in drug manufacturing and delivery, BASF offers solutions for Biopharma, Parenteral, […]
read more
New Member: Welcome in our cluster to Fab’ulous SAS
Fabulous accelerates antibody discovery with a fully computational, AI-powered approach that delivers preclinical ready human antibodies in just 3–5 days. Starting from your scientific problem, it designs candidates using curated human sequence data and in silico maturation to mimic natural immune evolution. This process enhances affinity, thermostability, and expression while reducing off-target binding. Each sequence […]
read more
